DCM
DGS Capital Management’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $3.51M | Sell |
40,795
-1,208
| -3% | -$104K | 0.88% | 17 |
|
|
2024
Q3 | $5M | Sell |
42,003
-381
| -0.9% | -$45.4K | 1.36% | 10 |
|
|
2024
Q2 | $6.05M | Sell |
42,384
-504
| -1% | -$71.9K | 1.7% | 9 |
|
|
2024
Q1 | $5.51M | Buy |
42,888
+1,151
| +3% | +$148K | 1.56% | 9 |
|
|
2023
Q4 | $4.32M | Sell |
41,737
-582
| -1% | -$60.2K | 1.66% | 7 |
|
|
2023
Q3 | $3.85M | Buy |
42,319
+21,382
| +102% | +$1.94M | 1.88% | 7 |
|
|
2023
Q2 | $3.39M | Sell |
20,937
-56
| -0.3% | -$9.06K | 1.69% | 7 |
|
|
2023
Q1 | $3.34M | Buy |
20,993
+6
| +0% | +$955 | 1.86% | 7 |
|
|
2022
Q4 | $2.84M | Sell |
20,987
-299
| -1% | -$40.5K | 1.86% | 7 |
|
|
2022
Q3 | $2.12M | Buy |
21,286
+1,189
| +6% | +$118K | 1.42% | 8 |
|
|
2022
Q2 | $2.24M | Sell |
20,097
-336
| -2% | -$37.4K | 1.81% | 8 |
|
|
2022
Q1 | $2.27M | Buy |
20,433
+2,621
| +15% | +$291K | 1.39% | 8 |
|
|
2021
Q4 | $2M | Buy |
+17,812
| New | +$2M | 1.24% | 9 |
|